60
Participants
Start Date
April 11, 2019
Primary Completion Date
September 30, 2026
Study Completion Date
December 31, 2026
Drug Response Predictor® (DRP)
A DRP is an assay that based on samples from a tumor can predict whether the tumor will respond to a specific drug or not.
OU Health Stephenson Cancer Center, Oklahoma City
Swedish Center for Research and Innovation, Seattle
Dana-Farber Cancer Institute, Boston
Beatson West of Scotland Cancer Centre, Glasgow
Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London
Lead Sponsor
Collaborators (1)
Amarex Clinical Research
OTHER
Allarity Therapeutics
INDUSTRY